Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Plos Genetics|November 9, 2013
The inactivation of Arx in pancreatic α-cells triggers their neogenesis and conversion into functional β-like cellsMonica Courtney, Elisabet Gjernes, Noémie Druelle, et al.
BMC Infectious Diseases|November 1, 2014
Visceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patientsMatteo Vassallo, Olivier Moranne, Damien Ambrosetti, et al.
Histopathology|May 14, 2022
Comprehensive study of nine novel cases of TFEB-amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expressionSolène-Florence Kammerer-Jacquet, Camille Gandon, Frederic Dugay, et al.
World Journal of Urology|January 12, 2023
Oncocytoma on renal mass biopsy: is it still the same histology when surgery is performed? Results from UroCCR-104 studyNicolas Branger, Pierre Bigot, Géraldine Pignot, et al.
Nature Communications|May 1, 2015
Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasisMélanie Tichet, Virginie Prod'Homme, Nina Fenouille, et al.
Cancer Research|May 9, 2019
PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer AggressivenessLisa Kaminski, Stéphanie Torrino, Maeva Dufies, et al.
Urologic Oncology|November 27, 2024
Delayed partial nephrectomy following complete response to immunotherapy: feasibility and results (UroCCR n°157)Gaëlle Margue, Clément Klein, Bastien Parier, et al.
Developmental Cell|July 2, 2013
Adult duct-lining cells can reprogram into β-like cells able to counter repeated cycles of toxin-induced diabetesKeith Al-Hasani, Anja Pfeifer, Monica Courtney, et al.
Molecular Cancer|October 21, 2021
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progressionLindsay S Cooley, Justine Rudewicz, Wilfried Souleyreau, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 20, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, et al.
Pageof 9